India biopharma will be $200 billion; industry by 2020
The biopharma market in India is growing at an annual growth rate of 15 percent. By 2020, the market is projected to be worth over 938,688 cr ($200 bn), driven largely by
...
a shift in usage from conventional drugs to biopharma products, the relatively high cost of biopharma products, the launch of biosimilars and a new generation of biotherapeutics.This was stated by Ashok Kumar, secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, Government of India, while inaugurating the National Convention on Biopharma, organized by the Department of Pharmaceuticals (DoP) and Federation of Indian Chambers of Commerce and Industries (FICCI) in association with the Department of Biotechnology (DBT) and the Association of Biotechnology Led Enterprises (ABLE) in NewDelhi on July 12, 2010. On the occasion, Ashok Kumar released the 'Vision 2020' document titled 'Leadership in Affordable Therapeutic Products: A BioPharma Strategy for India', prepared by PricewaterhouseCoopers and ABLE.
Link: http://biospectrumindia.ciol.com:50080/content/news/11008051.asp
Comment feed for this post
